

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.90404619 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.43152708 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.43152708 |
| 4 | righting reflex (GO:0060013) | 6.19396379 |
| 5 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 6.14798763 |
| 6 | negative T cell selection (GO:0043383) | 6.13515452 |
| 7 | protein K11-linked deubiquitination (GO:0035871) | 5.98481133 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.94106207 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.77040028 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.67724063 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.60917843 |
| 12 | dendritic spine morphogenesis (GO:0060997) | 5.41998123 |
| 13 | indolalkylamine metabolic process (GO:0006586) | 5.34364579 |
| 14 | positive T cell selection (GO:0043368) | 5.30172206 |
| 15 | reflex (GO:0060004) | 5.28323492 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.22733498 |
| 17 | positive thymic T cell selection (GO:0045059) | 5.11112019 |
| 18 | T cell selection (GO:0045058) | 4.75239461 |
| 19 | regulation of sarcomere organization (GO:0060297) | 4.71131634 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.70929271 |
| 21 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.68208811 |
| 22 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.68208811 |
| 23 | thymic T cell selection (GO:0045061) | 4.63593634 |
| 24 | response to interleukin-15 (GO:0070672) | 4.63045682 |
| 25 | neural tube formation (GO:0001841) | 4.61230737 |
| 26 | interferon-gamma production (GO:0032609) | 4.59113033 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.40668074 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 4.32645906 |
| 29 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 4.26388652 |
| 30 | detection of light stimulus involved in visual perception (GO:0050908) | 4.26062103 |
| 31 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.26062103 |
| 32 | tooth mineralization (GO:0034505) | 4.24776369 |
| 33 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.18280402 |
| 34 | positive regulation of humoral immune response (GO:0002922) | 4.15053134 |
| 35 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.12595175 |
| 36 | vocalization behavior (GO:0071625) | 4.11730037 |
| 37 | T cell receptor signaling pathway (GO:0050852) | 4.04851343 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.02784194 |
| 39 | tachykinin receptor signaling pathway (GO:0007217) | 4.02450003 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.98831348 |
| 41 | seminiferous tubule development (GO:0072520) | 3.92943261 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.92916258 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92916258 |
| 44 | chemosensory behavior (GO:0007635) | 3.91537867 |
| 45 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.87302828 |
| 46 | indole-containing compound metabolic process (GO:0042430) | 3.86642225 |
| 47 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.81354097 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.79592672 |
| 49 | NAD biosynthetic process (GO:0009435) | 3.76302848 |
| 50 | T cell costimulation (GO:0031295) | 3.75174228 |
| 51 | leukocyte aggregation (GO:0070486) | 3.73389612 |
| 52 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.73076243 |
| 53 | T cell migration (GO:0072678) | 3.70150404 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.69273843 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66446884 |
| 56 | response to misfolded protein (GO:0051788) | 3.65027432 |
| 57 | enteric nervous system development (GO:0048484) | 3.64879224 |
| 58 | tryptophan catabolic process (GO:0006569) | 3.63404663 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 3.63404663 |
| 60 | indolalkylamine catabolic process (GO:0046218) | 3.63404663 |
| 61 | regulation of female gonad development (GO:2000194) | 3.61116391 |
| 62 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.60112038 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.59616619 |
| 64 | aromatic amino acid family catabolic process (GO:0009074) | 3.56361221 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55795811 |
| 66 | glycine transport (GO:0015816) | 3.53634243 |
| 67 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.53533194 |
| 68 | positive regulation of interleukin-2 production (GO:0032743) | 3.51340901 |
| 69 | nucleoside diphosphate catabolic process (GO:0009134) | 3.47788693 |
| 70 | L-phenylalanine catabolic process (GO:0006559) | 3.47698088 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.47698088 |
| 72 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.47560807 |
| 73 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.44983207 |
| 74 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.44524656 |
| 75 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.44524656 |
| 76 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.44524656 |
| 77 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.44119435 |
| 78 | protein localization to synapse (GO:0035418) | 3.42487764 |
| 79 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.42160878 |
| 80 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.41179859 |
| 81 | detection of chemical stimulus (GO:0009593) | 3.40414992 |
| 82 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.38778642 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.38647311 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.36741907 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 3.36003389 |
| 86 | positive regulation of protein sumoylation (GO:0033235) | 3.35758359 |
| 87 | tryptophan metabolic process (GO:0006568) | 3.35684352 |
| 88 | serotonin metabolic process (GO:0042428) | 3.32142077 |
| 89 | L-phenylalanine metabolic process (GO:0006558) | 3.31283594 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31283594 |
| 91 | kynurenine metabolic process (GO:0070189) | 3.30787086 |
| 92 | V(D)J recombination (GO:0033151) | 3.30206022 |
| 93 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.28747160 |
| 94 | signal peptide processing (GO:0006465) | 3.27943856 |
| 95 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.23546286 |
| 96 | tolerance induction (GO:0002507) | 3.22815831 |
| 97 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.22576823 |
| 98 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.15253858 |
| 99 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.14277592 |
| 100 | activation of protein kinase A activity (GO:0034199) | 3.10526419 |
| 101 | cellular biogenic amine catabolic process (GO:0042402) | 3.09215666 |
| 102 | amine catabolic process (GO:0009310) | 3.09215666 |
| 103 | NIK/NF-kappaB signaling (GO:0038061) | 3.07468023 |
| 104 | alpha-beta T cell activation (GO:0046631) | 3.06809603 |
| 105 | cellular potassium ion transport (GO:0071804) | 3.05282616 |
| 106 | potassium ion transmembrane transport (GO:0071805) | 3.05282616 |
| 107 | proline transport (GO:0015824) | 3.02946494 |
| 108 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.01632801 |
| 109 | activated T cell proliferation (GO:0050798) | 3.01111317 |
| 110 | positive regulation of isotype switching (GO:0045830) | 3.00253753 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.00222063 |
| 112 | gonadal mesoderm development (GO:0007506) | 2.99703188 |
| 113 | regulation of response to interferon-gamma (GO:0060330) | 2.99583746 |
| 114 | alpha-beta T cell differentiation (GO:0046632) | 2.98341380 |
| 115 | primary amino compound metabolic process (GO:1901160) | 2.98252321 |
| 116 | positive regulation of immunoglobulin production (GO:0002639) | 2.97367209 |
| 117 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95351761 |
| 118 | behavioral response to nicotine (GO:0035095) | 2.94892427 |
| 119 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.94785954 |
| 120 | positive regulation of B cell mediated immunity (GO:0002714) | 2.94785954 |
| 121 | cAMP biosynthetic process (GO:0006171) | 2.93824252 |
| 122 | T cell differentiation (GO:0030217) | 2.92693115 |
| 123 | regulation of cAMP-mediated signaling (GO:0043949) | 2.92415751 |
| 124 | urea cycle (GO:0000050) | 2.91693042 |
| 125 | urea metabolic process (GO:0019627) | 2.91693042 |
| 126 | protein localization to cilium (GO:0061512) | 2.91613302 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.90706063 |
| 128 | synaptic transmission, dopaminergic (GO:0001963) | 2.90005810 |
| 129 | positive regulation of tolerance induction (GO:0002645) | 2.89376442 |
| 130 | T-helper cell differentiation (GO:0042093) | 2.88220398 |
| 131 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.88220398 |
| 132 | B cell receptor signaling pathway (GO:0050853) | 2.86739215 |
| 133 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.85707508 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83603082 |
| 135 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.83462422 |
| 136 | positive regulation of B cell differentiation (GO:0045579) | 2.83097848 |
| 137 | T cell homeostasis (GO:0043029) | 2.82161775 |
| 138 | positive regulation of steroid hormone secretion (GO:2000833) | 2.82048753 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81875652 |
| 140 | regulation of tolerance induction (GO:0002643) | 2.81089510 |
| 141 | behavioral response to ethanol (GO:0048149) | 2.80586897 |
| 142 | phospholipid efflux (GO:0033700) | 2.79889246 |
| 143 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.78090896 |
| 144 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.78090896 |
| 145 | regulation of immunoglobulin production (GO:0002637) | 2.76401262 |
| 146 | protein K48-linked deubiquitination (GO:0071108) | 2.76092489 |
| 147 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.75276904 |
| 148 | potassium ion transport (GO:0006813) | 2.75116149 |
| 149 | positive regulation of DNA recombination (GO:0045911) | 2.74875759 |
| 150 | valine metabolic process (GO:0006573) | 2.73883490 |
| 151 | auditory receptor cell stereocilium organization (GO:0060088) | 2.73752415 |
| 152 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73531909 |
| 153 | cell wall macromolecule metabolic process (GO:0044036) | 2.73423453 |
| 154 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.72691304 |
| 155 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.72261077 |
| 156 | serine family amino acid catabolic process (GO:0009071) | 2.72230535 |
| 157 | response to pheromone (GO:0019236) | 2.71490708 |
| 158 | regulation of isotype switching (GO:0045191) | 2.71483401 |
| 159 | drug transmembrane transport (GO:0006855) | 2.71457096 |
| 160 | embryonic epithelial tube formation (GO:0001838) | 2.70931227 |
| 161 | photoreceptor cell maintenance (GO:0045494) | 2.70874065 |
| 162 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.70817520 |
| 163 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.70666434 |
| 164 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.70666434 |
| 165 | negative regulation of cholesterol transport (GO:0032375) | 2.70400556 |
| 166 | negative regulation of sterol transport (GO:0032372) | 2.70400556 |
| 167 | cAMP metabolic process (GO:0046058) | 2.70019355 |
| 168 | drug catabolic process (GO:0042737) | 2.69376745 |
| 169 | negative regulation of type 2 immune response (GO:0002829) | 2.68243037 |
| 170 | hepatocyte apoptotic process (GO:0097284) | 2.68237807 |
| 171 | response to type I interferon (GO:0034340) | 2.67712835 |
| 172 | regulation of interleukin-2 production (GO:0032663) | 2.67370050 |
| 173 | regulation of neurotransmitter uptake (GO:0051580) | 2.66743254 |
| 174 | glycine metabolic process (GO:0006544) | 2.66635142 |
| 175 | aromatic amino acid family metabolic process (GO:0009072) | 2.66386587 |
| 176 | regulation of B cell mediated immunity (GO:0002712) | 2.66150946 |
| 177 | T cell activation (GO:0042110) | 2.62894142 |
| 178 | mast cell activation (GO:0045576) | 2.62360789 |
| 179 | cellular ketone body metabolic process (GO:0046950) | 2.61708390 |
| 180 | adaptation of signaling pathway (GO:0023058) | 2.61558838 |
| 181 | positive regulation of membrane potential (GO:0045838) | 2.60742957 |
| 182 | T cell differentiation involved in immune response (GO:0002292) | 2.60609124 |
| 183 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.60609124 |
| 184 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.60609124 |
| 185 | lymphocyte homeostasis (GO:0002260) | 2.60536293 |
| 186 | icosanoid secretion (GO:0032309) | 2.60456679 |
| 187 | arachidonic acid secretion (GO:0050482) | 2.60456679 |
| 188 | cellular response to type I interferon (GO:0071357) | 2.59549580 |
| 189 | type I interferon signaling pathway (GO:0060337) | 2.59549580 |
| 190 | positive regulation of RNA splicing (GO:0033120) | 2.59465253 |
| 191 | bile acid biosynthetic process (GO:0006699) | 2.59325052 |
| 192 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.59261029 |
| 193 | nitrogen cycle metabolic process (GO:0071941) | 2.57324737 |
| 194 | negative regulation of T cell mediated immunity (GO:0002710) | 2.55685960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.03366430 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61944634 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.33976311 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.31735346 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.21511427 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95726888 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 3.82619689 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.82570640 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.62132583 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.21600100 |
| 11 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.12751221 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.02904130 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.96865658 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.95948649 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85500021 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.82234411 |
| 17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.74970253 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73639508 |
| 19 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.70037454 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.68943365 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.60757416 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60202954 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.59405300 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.54285092 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.53528807 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53038829 |
| 27 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49776654 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.40786117 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38790937 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37813730 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.36292508 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.32756763 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.31181884 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29356800 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.25878146 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.21800118 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.20900847 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.17830067 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15047921 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08885405 |
| 41 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08486414 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07099233 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00195072 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99624571 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.99624571 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97168506 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.89020355 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.87481750 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87011290 |
| 50 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78499103 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78388539 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76346872 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.74485984 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.73941540 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69602084 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.67592198 |
| 57 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65781537 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65610323 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64691019 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64682494 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63507656 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61427227 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60665347 |
| 64 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56381872 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55946539 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51852023 |
| 67 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51124892 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49606064 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49531384 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49408024 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48751656 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48521490 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48496878 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48344434 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.47607690 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47051454 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45413956 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45359822 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45260657 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.44966788 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43857503 |
| 82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42777317 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41752667 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40739568 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40617457 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40243080 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39794508 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39569527 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39569527 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37695490 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35797775 |
| 92 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34993223 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33762479 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33669365 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32583328 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31756441 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30560616 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30501794 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30242726 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29896842 |
| 101 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29039565 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28642159 |
| 103 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28387269 |
| 104 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27474214 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26836193 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24336242 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23954611 |
| 108 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23329227 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22915150 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.22643449 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22493427 |
| 112 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22266060 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21982146 |
| 114 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21765860 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21631798 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21278122 |
| 117 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19302253 |
| 118 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18854202 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15952289 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15780520 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15628360 |
| 122 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15263275 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14345591 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14249539 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14249539 |
| 126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13844895 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11420055 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10091204 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10024056 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09578084 |
| 131 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09031214 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08789897 |
| 133 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08486442 |
| 134 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08152618 |
| 135 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07191162 |
| 136 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06954201 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05761182 |
| 138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05748036 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05616023 |
| 140 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05203996 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04921507 |
| 142 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04468673 |
| 143 | EWS_26573619_Chip-Seq_HEK293_Human | 1.04453299 |
| 144 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04208298 |
| 145 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03951778 |
| 146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03327426 |
| 147 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03238596 |
| 148 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02718317 |
| 149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01909599 |
| 150 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01581726 |
| 151 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01189431 |
| 152 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00999088 |
| 153 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00765085 |
| 154 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00657735 |
| 155 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00371646 |
| 156 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99961933 |
| 157 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99958667 |
| 158 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99758200 |
| 159 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99724800 |
| 160 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.99309051 |
| 161 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99237079 |
| 162 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99123310 |
| 163 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99012215 |
| 164 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99012215 |
| 165 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98878130 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98665758 |
| 167 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97984097 |
| 168 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97459749 |
| 169 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96860091 |
| 170 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.96505232 |
| 171 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96185002 |
| 172 | NFYA_21822215_ChIP-Seq_K562_Human | 0.96086148 |
| 173 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95850444 |
| 174 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94862489 |
| 175 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94832703 |
| 176 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93259711 |
| 177 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91306128 |
| 178 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90565440 |
| 179 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88563117 |
| 180 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87286733 |
| 181 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87210414 |
| 182 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85128907 |
| 183 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.84665272 |
| 184 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.84593177 |
| 185 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83746195 |
| 186 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83729738 |
| 187 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83301970 |
| 188 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83127965 |
| 189 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82010819 |
| 190 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80539308 |
| 191 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79843424 |
| 192 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78050769 |
| 193 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75443554 |
| 194 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.74508911 |
| 195 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73396624 |
| 196 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70161581 |
| 197 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.69231664 |
| 198 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.68653310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005084_abnormal_gallbladder_morpholo | 4.72274267 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.36657098 |
| 3 | MP0001501_abnormal_sleep_pattern | 3.87605698 |
| 4 | MP0005360_urolithiasis | 3.57685704 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.38812239 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.32178728 |
| 7 | MP0000685_abnormal_immune_system | 3.26886473 |
| 8 | MP0005671_abnormal_response_to | 3.24094641 |
| 9 | MP0008961_abnormal_basal_metabolism | 3.19163135 |
| 10 | MP0005365_abnormal_bile_salt | 2.99976358 |
| 11 | MP0001800_abnormal_humoral_immune | 2.92723634 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.80589599 |
| 13 | MP0001790_abnormal_immune_system | 2.76336520 |
| 14 | MP0005387_immune_system_phenotype | 2.76336520 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.64944154 |
| 16 | MP0003878_abnormal_ear_physiology | 2.64944154 |
| 17 | MP0002822_catalepsy | 2.43059196 |
| 18 | MP0002398_abnormal_bone_marrow | 2.34127314 |
| 19 | MP0002723_abnormal_immune_serum | 2.34078185 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.29064551 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.28689849 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.26499644 |
| 23 | MP0009785_altered_susceptibility_to | 2.24296090 |
| 24 | MP0001819_abnormal_immune_cell | 2.23464857 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.23274502 |
| 26 | MP0009745_abnormal_behavioral_response | 2.20849515 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.17818998 |
| 28 | MP0001905_abnormal_dopamine_level | 2.14904544 |
| 29 | MP0003436_decreased_susceptibility_to | 2.14829712 |
| 30 | MP0001968_abnormal_touch/_nociception | 2.13558509 |
| 31 | MP0008872_abnormal_physiological_respon | 2.11530504 |
| 32 | MP0000716_abnormal_immune_system | 2.10145144 |
| 33 | MP0005670_abnormal_white_adipose | 2.09888593 |
| 34 | MP0005025_abnormal_response_to | 2.08251060 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06624382 |
| 36 | MP0005423_abnormal_somatic_nervous | 2.06054339 |
| 37 | MP0000703_abnormal_thymus_morphology | 2.04620640 |
| 38 | MP0004130_abnormal_muscle_cell | 2.04275616 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 2.00491830 |
| 40 | MP0003646_muscle_fatigue | 1.97459289 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.97293077 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.97204283 |
| 43 | MP0009046_muscle_twitch | 1.95132676 |
| 44 | MP0002722_abnormal_immune_system | 1.92255312 |
| 45 | MP0003252_abnormal_bile_duct | 1.90489724 |
| 46 | MP0001873_stomach_inflammation | 1.89766330 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.88299897 |
| 48 | MP0002006_tumorigenesis | 1.85925772 |
| 49 | MP0004381_abnormal_hair_follicle | 1.84924145 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.80782412 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.80275244 |
| 52 | MP0002405_respiratory_system_inflammati | 1.79542003 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.79297709 |
| 54 | MP0004043_abnormal_pH_regulation | 1.75745484 |
| 55 | MP0009840_abnormal_foam_cell | 1.74276411 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.73265538 |
| 57 | MP0002429_abnormal_blood_cell | 1.72830128 |
| 58 | MP0006082_CNS_inflammation | 1.66164224 |
| 59 | MP0004947_skin_inflammation | 1.64034822 |
| 60 | MP0002736_abnormal_nociception_after | 1.63594668 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.62858995 |
| 62 | MP0001486_abnormal_startle_reflex | 1.62777347 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.62330382 |
| 64 | MP0001853_heart_inflammation | 1.62171250 |
| 65 | MP0002419_abnormal_innate_immunity | 1.61699442 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.60930908 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.60009380 |
| 68 | MP0005646_abnormal_pituitary_gland | 1.59882753 |
| 69 | MP0004142_abnormal_muscle_tone | 1.59246334 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.57716047 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.57663002 |
| 72 | MP0000609_abnormal_liver_physiology | 1.56631019 |
| 73 | MP0003724_increased_susceptibility_to | 1.56528514 |
| 74 | MP0001485_abnormal_pinna_reflex | 1.56518858 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.54979144 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.54949614 |
| 77 | MP0003880_abnormal_central_pattern | 1.54305536 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.51436018 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 1.48732829 |
| 80 | MP0003866_abnormal_defecation | 1.48134694 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.48074601 |
| 82 | MP0003136_yellow_coat_color | 1.45114058 |
| 83 | MP0002132_abnormal_respiratory_system | 1.42048913 |
| 84 | MP0003635_abnormal_synaptic_transmissio | 1.41965663 |
| 85 | MP0003718_maternal_effect | 1.41780203 |
| 86 | MP0005448_abnormal_energy_balance | 1.40672718 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 1.40627242 |
| 88 | MP0001970_abnormal_pain_threshold | 1.38884470 |
| 89 | MP0010329_abnormal_lipoprotein_level | 1.37784228 |
| 90 | MP0008057_abnormal_DNA_replication | 1.37059471 |
| 91 | MP0002933_joint_inflammation | 1.35956864 |
| 92 | MP0008469_abnormal_protein_level | 1.34890406 |
| 93 | MP0004133_heterotaxia | 1.31335522 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.27050839 |
| 95 | MP0002272_abnormal_nervous_system | 1.24824649 |
| 96 | MP0002064_seizures | 1.23533640 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.22102532 |
| 98 | MP0006072_abnormal_retinal_apoptosis | 1.21648461 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 1.21145298 |
| 100 | MP0009764_decreased_sensitivity_to | 1.19293339 |
| 101 | MP0000372_irregular_coat_pigmentation | 1.18600849 |
| 102 | MP0002909_abnormal_adrenal_gland | 1.16271018 |
| 103 | MP0005253_abnormal_eye_physiology | 1.14934914 |
| 104 | MP0003868_abnormal_feces_composition | 1.13920421 |
| 105 | MP0001666_abnormal_nutrient_absorption | 1.12181015 |
| 106 | MP0002693_abnormal_pancreas_physiology | 1.10693863 |
| 107 | MP0001764_abnormal_homeostasis | 1.10558356 |
| 108 | MP0005220_abnormal_exocrine_pancreas | 1.10493068 |
| 109 | MP0003045_fibrosis | 1.10181560 |
| 110 | MP0002751_abnormal_autonomic_nervous | 1.06885703 |
| 111 | MP0002067_abnormal_sensory_capabilities | 1.06855292 |
| 112 | MP0010386_abnormal_urinary_bladder | 1.06348782 |
| 113 | MP0004147_increased_porphyrin_level | 1.06116268 |
| 114 | MP0000470_abnormal_stomach_morphology | 1.05778174 |
| 115 | MP0009763_increased_sensitivity_to | 1.05448917 |
| 116 | MP0001986_abnormal_taste_sensitivity | 1.05183360 |
| 117 | MP0005083_abnormal_biliary_tract | 1.04043679 |
| 118 | MP0005451_abnormal_body_composition | 1.03897908 |
| 119 | MP0001963_abnormal_hearing_physiology | 1.03835876 |
| 120 | MP0005332_abnormal_amino_acid | 1.02437744 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 1.02127547 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 1.01628467 |
| 123 | MP0002876_abnormal_thyroid_physiology | 1.01309522 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.99567866 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.99330975 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.99330975 |
| 127 | MP0006292_abnormal_olfactory_placode | 0.98380043 |
| 128 | MP0003879_abnormal_hair_cell | 0.98334664 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.98152289 |
| 130 | MP0002734_abnormal_mechanical_nocicepti | 0.97655011 |
| 131 | MP0004885_abnormal_endolymph | 0.97374585 |
| 132 | MP0000490_abnormal_crypts_of | 0.96497671 |
| 133 | MP0003303_peritoneal_inflammation | 0.94718016 |
| 134 | MP0005310_abnormal_salivary_gland | 0.93836768 |
| 135 | MP0001529_abnormal_vocalization | 0.93276811 |
| 136 | MP0008058_abnormal_DNA_repair | 0.93094339 |
| 137 | MP0002653_abnormal_ependyma_morphology | 0.92925206 |
| 138 | MP0001984_abnormal_olfaction | 0.92706553 |
| 139 | MP0010094_abnormal_chromosome_stability | 0.92541183 |
| 140 | MP0002063_abnormal_learning/memory/cond | 0.91635557 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.91015848 |
| 142 | MP0005410_abnormal_fertilization | 0.90461133 |
| 143 | MP0000598_abnormal_liver_morphology | 0.89815932 |
| 144 | MP0002234_abnormal_pharynx_morphology | 0.88471400 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.85340632 |
| 146 | MP0004510_myositis | 0.84746894 |
| 147 | MP0000465_gastrointestinal_hemorrhage | 0.84569786 |
| 148 | MP0002229_neurodegeneration | 0.84550612 |
| 149 | MP0009697_abnormal_copulation | 0.84339554 |
| 150 | MP0000858_altered_metastatic_potential | 0.84250580 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.84177011 |
| 152 | MP0005171_absent_coat_pigmentation | 0.83224785 |
| 153 | MP0004742_abnormal_vestibular_system | 0.82163265 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.82079551 |
| 155 | MP0003693_abnormal_embryo_hatching | 0.81806778 |
| 156 | MP0005395_other_phenotype | 0.81713263 |
| 157 | MP0001944_abnormal_pancreas_morphology | 0.80893839 |
| 158 | MP0000026_abnormal_inner_ear | 0.79125905 |
| 159 | MP0003953_abnormal_hormone_level | 0.77918978 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77510546 |
| 161 | MP0002078_abnormal_glucose_homeostasis | 0.76251722 |
| 162 | MP0003633_abnormal_nervous_system | 0.75281845 |
| 163 | MP0002752_abnormal_somatic_nervous | 0.74856534 |
| 164 | MP0004019_abnormal_vitamin_homeostasis | 0.73984789 |
| 165 | MP0003077_abnormal_cell_cycle | 0.73408139 |
| 166 | MP0009643_abnormal_urine_homeostasis | 0.72325406 |
| 167 | MP0005386_behavior/neurological_phenoty | 0.71805077 |
| 168 | MP0004924_abnormal_behavior | 0.71805077 |
| 169 | MP0000639_abnormal_adrenal_gland | 0.71622728 |
| 170 | MP0002136_abnormal_kidney_physiology | 0.71196172 |
| 171 | MP0003950_abnormal_plasma_membrane | 0.70781825 |
| 172 | MP0004264_abnormal_extraembryonic_tissu | 0.69912254 |
| 173 | MP0002118_abnormal_lipid_homeostasis | 0.69688584 |
| 174 | MP0008569_lethality_at_weaning | 0.68781489 |
| 175 | MP0000427_abnormal_hair_cycle | 0.68458100 |
| 176 | MP0002102_abnormal_ear_morphology | 0.68215203 |
| 177 | MP0005266_abnormal_metabolism | 0.68037910 |
| 178 | MP0002928_abnormal_bile_duct | 0.65223262 |
| 179 | MP0003195_calcinosis | 0.65061645 |
| 180 | MP0005174_abnormal_tail_pigmentation | 0.64753578 |
| 181 | MP0001533_abnormal_skeleton_physiology | 0.63931494 |
| 182 | MP0009278_abnormal_bone_marrow | 0.63595026 |
| 183 | MP0005647_abnormal_sex_gland | 0.62382902 |
| 184 | MP0002009_preneoplasia | 0.61931463 |
| 185 | MP0001243_abnormal_dermal_layer | 0.58759610 |
| 186 | MP0009642_abnormal_blood_homeostasis | 0.57023305 |
| 187 | MP0003186_abnormal_redox_activity | 0.56090969 |
| 188 | MP0003448_altered_tumor_morphology | 0.53448258 |
| 189 | MP0003453_abnormal_keratinocyte_physiol | 0.51310249 |
| 190 | MP0000477_abnormal_intestine_morphology | 0.50338464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.08160603 |
| 2 | Genetic anticipation (HP:0003743) | 5.98352053 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.97177732 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 4.61811972 |
| 5 | Recurrent viral infections (HP:0004429) | 4.58459715 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.54164646 |
| 7 | Abnormality of T cells (HP:0002843) | 4.49611912 |
| 8 | Decreased central vision (HP:0007663) | 4.48523160 |
| 9 | Congenital stationary night blindness (HP:0007642) | 4.34519720 |
| 10 | Recurrent bronchitis (HP:0002837) | 4.29780205 |
| 11 | Abnormality of B cell number (HP:0010975) | 4.24745089 |
| 12 | B lymphocytopenia (HP:0010976) | 4.24745089 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.16948789 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 4.10669406 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.05181394 |
| 16 | Chronic otitis media (HP:0000389) | 4.04917476 |
| 17 | Combined immunodeficiency (HP:0005387) | 4.03935575 |
| 18 | Retinal dysplasia (HP:0007973) | 3.76619359 |
| 19 | IgG deficiency (HP:0004315) | 3.75442116 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68897897 |
| 21 | Abnormality of binocular vision (HP:0011514) | 3.58854786 |
| 22 | Diplopia (HP:0000651) | 3.58854786 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.58613051 |
| 24 | Eosinophilia (HP:0001880) | 3.58165122 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57761080 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57761080 |
| 27 | IgM deficiency (HP:0002850) | 3.56941743 |
| 28 | Polyuria (HP:0000103) | 3.51425830 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.47107457 |
| 30 | Amelogenesis imperfecta (HP:0000705) | 3.44340744 |
| 31 | Joint swelling (HP:0001386) | 3.43940811 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 3.39191966 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 3.39033014 |
| 34 | Hyperventilation (HP:0002883) | 3.36668170 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 3.34813083 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 3.34813083 |
| 37 | Nasal polyposis (HP:0100582) | 3.31796058 |
| 38 | Chronic diarrhea (HP:0002028) | 3.30745792 |
| 39 | Recurrent sinusitis (HP:0011108) | 3.29301605 |
| 40 | Pustule (HP:0200039) | 3.25339314 |
| 41 | Agammaglobulinemia (HP:0004432) | 3.24328793 |
| 42 | Hypoplasia of the thymus (HP:0000778) | 3.24045547 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 3.22120211 |
| 44 | Granulocytopenia (HP:0001913) | 3.22035342 |
| 45 | Deep venous thrombosis (HP:0002625) | 3.19230368 |
| 46 | Abnormality of eosinophils (HP:0001879) | 3.18453013 |
| 47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18332163 |
| 48 | Nephronophthisis (HP:0000090) | 3.17689030 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 3.16643613 |
| 50 | Abnormality of dental color (HP:0011073) | 3.11279658 |
| 51 | Thyroiditis (HP:0100646) | 3.10771188 |
| 52 | Pancreatic cysts (HP:0001737) | 3.09012462 |
| 53 | Abnormality of the fingertips (HP:0001211) | 3.02938387 |
| 54 | Stomatitis (HP:0010280) | 3.02182719 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 3.01038205 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.99925073 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.99717977 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.97698669 |
| 59 | Joint hemorrhage (HP:0005261) | 2.97597007 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.94530037 |
| 61 | Meningitis (HP:0001287) | 2.93616701 |
| 62 | Lymphopenia (HP:0001888) | 2.92868771 |
| 63 | Abnormal urine output (HP:0012590) | 2.91601511 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89666056 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 2.89638085 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.85719340 |
| 67 | Increased IgM level (HP:0003496) | 2.83106807 |
| 68 | IgA deficiency (HP:0002720) | 2.81843189 |
| 69 | Gingival bleeding (HP:0000225) | 2.81041951 |
| 70 | Decreased circulating renin level (HP:0003351) | 2.77725827 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 2.77181616 |
| 72 | Colitis (HP:0002583) | 2.76670726 |
| 73 | Vasculitis (HP:0002633) | 2.75555712 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.74572529 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.72346414 |
| 76 | Abnormality of macular pigmentation (HP:0008002) | 2.70562391 |
| 77 | Encephalitis (HP:0002383) | 2.69414639 |
| 78 | Xanthomatosis (HP:0000991) | 2.69351247 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.67897425 |
| 80 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.67897425 |
| 81 | Myositis (HP:0100614) | 2.65332234 |
| 82 | Recurrent skin infections (HP:0001581) | 2.63939327 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.61983265 |
| 84 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.60505479 |
| 85 | Leukocytosis (HP:0001974) | 2.58660429 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.58232458 |
| 87 | Severe visual impairment (HP:0001141) | 2.56320976 |
| 88 | Pancreatic fibrosis (HP:0100732) | 2.51816280 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.51099128 |
| 90 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50802108 |
| 91 | Chronic hepatic failure (HP:0100626) | 2.49436692 |
| 92 | Febrile seizures (HP:0002373) | 2.49244638 |
| 93 | Chronic sinusitis (HP:0011109) | 2.48818275 |
| 94 | Abnormality of renal excretion (HP:0011036) | 2.48812556 |
| 95 | Hypothermia (HP:0002045) | 2.47161248 |
| 96 | Keratoconus (HP:0000563) | 2.47107664 |
| 97 | Increased corneal curvature (HP:0100692) | 2.47107664 |
| 98 | Focal seizures (HP:0007359) | 2.46450888 |
| 99 | Focal motor seizures (HP:0011153) | 2.45810995 |
| 100 | Sclerocornea (HP:0000647) | 2.45645666 |
| 101 | Bronchitis (HP:0012387) | 2.45021950 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 2.44774159 |
| 103 | Polydipsia (HP:0001959) | 2.42041922 |
| 104 | Abnormal drinking behavior (HP:0030082) | 2.42041922 |
| 105 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40374205 |
| 106 | Myocardial infarction (HP:0001658) | 2.40262285 |
| 107 | Abnormality of methionine metabolism (HP:0010901) | 2.39753457 |
| 108 | Mitral stenosis (HP:0001718) | 2.39442943 |
| 109 | Epistaxis (HP:0000421) | 2.38769137 |
| 110 | Chronic bronchitis (HP:0004469) | 2.37897823 |
| 111 | Verrucae (HP:0200043) | 2.35045492 |
| 112 | Papilloma (HP:0012740) | 2.35045492 |
| 113 | Spontaneous hematomas (HP:0007420) | 2.34792676 |
| 114 | Gastrointestinal infarctions (HP:0005244) | 2.34694943 |
| 115 | Lymphoma (HP:0002665) | 2.34253848 |
| 116 | True hermaphroditism (HP:0010459) | 2.32455933 |
| 117 | Inability to walk (HP:0002540) | 2.32045689 |
| 118 | Clumsiness (HP:0002312) | 2.31027281 |
| 119 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30501124 |
| 120 | Stomach cancer (HP:0012126) | 2.28455071 |
| 121 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.28154111 |
| 122 | Dialeptic seizures (HP:0011146) | 2.26337118 |
| 123 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.25936627 |
| 124 | Recurrent otitis media (HP:0000403) | 2.24467950 |
| 125 | Cystic liver disease (HP:0006706) | 2.24437909 |
| 126 | Central scotoma (HP:0000603) | 2.23615354 |
| 127 | Mediastinal lymphadenopathy (HP:0100721) | 2.23109279 |
| 128 | Macular degeneration (HP:0000608) | 2.21690092 |
| 129 | Protruding tongue (HP:0010808) | 2.20904357 |
| 130 | Hypochromic anemia (HP:0001931) | 2.19924764 |
| 131 | Type II lissencephaly (HP:0007260) | 2.19844857 |
| 132 | Abnormal ciliary motility (HP:0012262) | 2.18954433 |
| 133 | Cerebellar dysplasia (HP:0007033) | 2.18838155 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18617760 |
| 135 | Pulmonary embolism (HP:0002204) | 2.17662804 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16681785 |
| 137 | Cheilitis (HP:0100825) | 2.15207797 |
| 138 | Congenital sensorineural hearing impairment (HP:0008527) | 2.14547308 |
| 139 | Hypoplasia of the fovea (HP:0007750) | 2.13198794 |
| 140 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.13198794 |
| 141 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13014409 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 2.12847450 |
| 143 | Recurrent abscess formation (HP:0002722) | 2.12810993 |
| 144 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.12714636 |
| 145 | Recurrent bacterial skin infections (HP:0005406) | 2.12696390 |
| 146 | Abnormality of renin-angiotensin system (HP:0000847) | 2.12633242 |
| 147 | Absent speech (HP:0001344) | 2.09098244 |
| 148 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08507732 |
| 149 | Widely spaced teeth (HP:0000687) | 2.07463435 |
| 150 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.06475551 |
| 151 | Conjugated hyperbilirubinemia (HP:0002908) | 2.06403468 |
| 152 | Abnormal protein glycosylation (HP:0012346) | 2.04925515 |
| 153 | Abnormal glycosylation (HP:0012345) | 2.04925515 |
| 154 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.04925515 |
| 155 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.04925515 |
| 156 | Hepatitis (HP:0012115) | 2.04711784 |
| 157 | Hypolipoproteinemia (HP:0010981) | 2.04054821 |
| 158 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03494763 |
| 159 | Abnormal platelet volume (HP:0011876) | 2.03285423 |
| 160 | Hemiparesis (HP:0001269) | 2.02931057 |
| 161 | Periodontitis (HP:0000704) | 2.01592632 |
| 162 | Ectopic kidney (HP:0000086) | 2.01482128 |
| 163 | Visual hallucinations (HP:0002367) | 2.01093248 |
| 164 | Hypochromic microcytic anemia (HP:0004840) | 2.00503906 |
| 165 | Hyperglycinemia (HP:0002154) | 2.00237328 |
| 166 | Medial flaring of the eyebrow (HP:0010747) | 1.99239090 |
| 167 | Hemoptysis (HP:0002105) | 1.99210612 |
| 168 | Prolonged bleeding time (HP:0003010) | 1.99190060 |
| 169 | Complement deficiency (HP:0004431) | 1.97761816 |
| 170 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96923582 |
| 171 | Renal cortical cysts (HP:0000803) | 1.96918229 |
| 172 | Hypoplasia of the pons (HP:0012110) | 1.95335295 |
| 173 | Constricted visual fields (HP:0001133) | 1.94029040 |
| 174 | Abnormality of the prostate (HP:0008775) | 1.93977251 |
| 175 | Hyperammonemia (HP:0001987) | 1.93850328 |
| 176 | Hypoplasia of the iris (HP:0007676) | 1.93478099 |
| 177 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93030837 |
| 178 | Volvulus (HP:0002580) | 1.92730247 |
| 179 | Pulmonary infiltrates (HP:0002113) | 1.92244503 |
| 180 | Thrombocytosis (HP:0001894) | 1.91642437 |
| 181 | Ketosis (HP:0001946) | 1.90639258 |
| 182 | Narrow nasal bridge (HP:0000446) | 1.88967517 |
| 183 | Hyperaldosteronism (HP:0000859) | 1.86876450 |
| 184 | Hypoplastic ischia (HP:0003175) | 1.85783957 |
| 185 | Intestinal atresia (HP:0011100) | 1.85198644 |
| 186 | Epileptic encephalopathy (HP:0200134) | 1.84285398 |
| 187 | Poikiloderma (HP:0001029) | 1.83736830 |
| 188 | Abnormality of the pubic bones (HP:0003172) | 1.83489082 |
| 189 | Abnormality of the pons (HP:0007361) | 1.83419072 |
| 190 | Absence seizures (HP:0002121) | 1.81940406 |
| 191 | Impaired smooth pursuit (HP:0007772) | 1.80133176 |
| 192 | Overgrowth (HP:0001548) | 1.77435604 |
| 193 | Broad-based gait (HP:0002136) | 1.73325682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.99772072 |
| 2 | INSRR | 5.46112768 |
| 3 | MAP4K1 | 5.43609806 |
| 4 | TXK | 4.67942930 |
| 5 | NTRK2 | 4.40598317 |
| 6 | FGFR4 | 3.36590870 |
| 7 | JAK3 | 2.99294618 |
| 8 | TYK2 | 2.85431965 |
| 9 | MAP3K14 | 2.78096263 |
| 10 | ZAP70 | 2.71723116 |
| 11 | GRK6 | 2.58782335 |
| 12 | IKBKE | 2.52740201 |
| 13 | ITK | 2.41550892 |
| 14 | MAP4K2 | 2.32194812 |
| 15 | STK10 | 2.25987314 |
| 16 | MAP3K10 | 2.21786899 |
| 17 | NLK | 2.19219309 |
| 18 | GRK1 | 2.00194411 |
| 19 | BMPR1B | 1.88360909 |
| 20 | JAK1 | 1.81409689 |
| 21 | TBK1 | 1.80708463 |
| 22 | MAP3K13 | 1.77633872 |
| 23 | CSK | 1.76635125 |
| 24 | STK3 | 1.75513554 |
| 25 | FGFR3 | 1.74681757 |
| 26 | TEC | 1.70661573 |
| 27 | SYK | 1.64673277 |
| 28 | LCK | 1.58325206 |
| 29 | NME2 | 1.55664871 |
| 30 | EEF2K | 1.52300389 |
| 31 | CASK | 1.52285713 |
| 32 | NTRK3 | 1.51841449 |
| 33 | BLK | 1.51080873 |
| 34 | IKBKB | 1.50915954 |
| 35 | BTK | 1.49592950 |
| 36 | CDK12 | 1.44991689 |
| 37 | ZAK | 1.43905114 |
| 38 | SIK3 | 1.41803691 |
| 39 | MST4 | 1.40045788 |
| 40 | MARK3 | 1.36344223 |
| 41 | BMPR2 | 1.34526101 |
| 42 | IRAK4 | 1.33015064 |
| 43 | HCK | 1.28296845 |
| 44 | PIM1 | 1.27860718 |
| 45 | STK38L | 1.27686177 |
| 46 | PTK2B | 1.27297390 |
| 47 | SIK1 | 1.26668772 |
| 48 | ADRBK1 | 1.23416830 |
| 49 | WNK3 | 1.21049256 |
| 50 | PINK1 | 1.18678451 |
| 51 | PRKCE | 1.15449377 |
| 52 | LATS1 | 1.13316641 |
| 53 | MAP3K7 | 1.13061567 |
| 54 | MAPK13 | 1.12487912 |
| 55 | NUAK1 | 1.10933582 |
| 56 | STK39 | 1.10049264 |
| 57 | DAPK2 | 1.08432312 |
| 58 | RIPK4 | 1.07741196 |
| 59 | PRKCQ | 1.07365138 |
| 60 | KIT | 1.06808350 |
| 61 | PIK3CG | 1.06534324 |
| 62 | CHUK | 1.05777797 |
| 63 | IRAK3 | 1.05004632 |
| 64 | CSF1R | 1.04722523 |
| 65 | WNK4 | 1.03991237 |
| 66 | ERN1 | 1.03914828 |
| 67 | MAPK11 | 1.01996198 |
| 68 | TNIK | 1.01041012 |
| 69 | OXSR1 | 1.01009636 |
| 70 | SIK2 | 0.99929216 |
| 71 | CDK4 | 0.98369593 |
| 72 | PASK | 0.91757423 |
| 73 | FLT3 | 0.90810646 |
| 74 | KDR | 0.90610094 |
| 75 | LYN | 0.89190376 |
| 76 | MUSK | 0.88726293 |
| 77 | TGFBR2 | 0.84379085 |
| 78 | ACVR1B | 0.83874268 |
| 79 | PKN2 | 0.83730136 |
| 80 | TAOK3 | 0.83007842 |
| 81 | FGFR2 | 0.82191823 |
| 82 | JAK2 | 0.81052081 |
| 83 | PRKAA1 | 0.80363113 |
| 84 | TLK1 | 0.79058353 |
| 85 | CLK1 | 0.76512006 |
| 86 | RPS6KA4 | 0.75070449 |
| 87 | CAMKK1 | 0.74039289 |
| 88 | PRKCH | 0.72127287 |
| 89 | STK4 | 0.68418927 |
| 90 | MAPK7 | 0.67403556 |
| 91 | LRRK2 | 0.67143957 |
| 92 | PRKAA2 | 0.66455357 |
| 93 | BRD4 | 0.66443075 |
| 94 | BCKDK | 0.64130807 |
| 95 | PRKCG | 0.63025919 |
| 96 | PAK3 | 0.61571431 |
| 97 | AKT3 | 0.61182096 |
| 98 | TRIM28 | 0.60360013 |
| 99 | EPHA3 | 0.59361178 |
| 100 | EPHB1 | 0.58759206 |
| 101 | NEK2 | 0.58379643 |
| 102 | MAP3K4 | 0.58019694 |
| 103 | GRK7 | 0.56454695 |
| 104 | CAMK1D | 0.52167171 |
| 105 | MAPK4 | 0.51773484 |
| 106 | CAMKK2 | 0.50128165 |
| 107 | CDK6 | 0.49579267 |
| 108 | CAMK2A | 0.48117418 |
| 109 | IRAK1 | 0.47775641 |
| 110 | TNK2 | 0.46861883 |
| 111 | PDK1 | 0.46789917 |
| 112 | SRPK1 | 0.45431214 |
| 113 | PLK2 | 0.44034775 |
| 114 | NEK9 | 0.43913467 |
| 115 | ATR | 0.42465170 |
| 116 | MELK | 0.42346172 |
| 117 | TESK2 | 0.42240867 |
| 118 | TSSK6 | 0.41159462 |
| 119 | PRKACA | 0.39700718 |
| 120 | CSNK1A1 | 0.39694937 |
| 121 | PDGFRB | 0.39693369 |
| 122 | PRKCA | 0.39275540 |
| 123 | CAMK4 | 0.39145088 |
| 124 | HIPK2 | 0.39046842 |
| 125 | PDK2 | 0.38880598 |
| 126 | FER | 0.38187508 |
| 127 | CAMK1G | 0.37812909 |
| 128 | WNK1 | 0.37418568 |
| 129 | VRK1 | 0.37193069 |
| 130 | STK38 | 0.37190261 |
| 131 | MAPK12 | 0.36494211 |
| 132 | CAMK1 | 0.36109297 |
| 133 | PKN1 | 0.35612066 |
| 134 | MAP2K6 | 0.35088567 |
| 135 | CDC42BPA | 0.34929314 |
| 136 | SGK3 | 0.34427653 |
| 137 | ADRBK2 | 0.34082818 |
| 138 | MAPK3 | 0.33876881 |
| 139 | TIE1 | 0.33612911 |
| 140 | YES1 | 0.33402415 |
| 141 | INSR | 0.33398871 |
| 142 | STK24 | 0.33219537 |
| 143 | RPS6KB2 | 0.32597161 |
| 144 | MAP2K3 | 0.32531383 |
| 145 | ERBB2 | 0.32209058 |
| 146 | EIF2AK3 | 0.31113325 |
| 147 | CDC7 | 0.31032490 |
| 148 | CDK9 | 0.28580071 |
| 149 | MKNK2 | 0.28089444 |
| 150 | PRKACB | 0.27346604 |
| 151 | STK11 | 0.27148654 |
| 152 | BRSK2 | 0.26374003 |
| 153 | FES | 0.26320376 |
| 154 | PTK6 | 0.25818779 |
| 155 | MARK2 | 0.25705666 |
| 156 | EIF2AK2 | 0.25627787 |
| 157 | ABL1 | 0.25337932 |
| 158 | GRK5 | 0.25149205 |
| 159 | MATK | 0.24894325 |
| 160 | PRKACG | 0.24616541 |
| 161 | PRKCB | 0.24168373 |
| 162 | TRPM7 | 0.23405325 |
| 163 | MAPKAPK3 | 0.23179211 |
| 164 | RPS6KA5 | 0.22348769 |
| 165 | RPS6KA3 | 0.22299101 |
| 166 | IGF1R | 0.22227121 |
| 167 | CHEK1 | 0.19989388 |
| 168 | ALK | 0.18051917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.88764142 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.25491327 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.88804611 |
| 4 | Taste transduction_Homo sapiens_hsa04742 | 2.83789437 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.71441725 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.65105549 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.63850221 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.59035814 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56964599 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.51693217 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40263725 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.32474017 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.20400223 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.18419206 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18259221 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18090502 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16464372 |
| 18 | Measles_Homo sapiens_hsa05162 | 2.15133113 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.03867526 |
| 20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.01212699 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00218954 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 2.00005330 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90568874 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.88897305 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.83982842 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.83259550 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.81386599 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78951035 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.70141975 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.68642030 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.67855384 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67061226 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.66853945 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66544952 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66448033 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62875694 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61290948 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61258005 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57888646 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56224549 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55308195 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54565494 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53599887 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50759378 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48827064 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48159628 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.47214831 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.43681970 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40193699 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39405461 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36771845 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35909911 |
| 53 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33021599 |
| 54 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29780299 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29658902 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27665050 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23796979 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23495354 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22706478 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.21982975 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16102254 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.15782810 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15573836 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13396109 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13212636 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13086903 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12693479 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12345990 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12312014 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12238232 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 1.11385865 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10377871 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09875381 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07471667 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 1.07350595 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06998219 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05578589 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05386787 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01709600 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00386640 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99760959 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98958052 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96914105 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93212604 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90776056 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.90731109 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90449283 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.87996894 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87995305 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87230012 |
| 91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86880312 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86397490 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.85631833 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84389544 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84107275 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83199294 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83037163 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.82673122 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81516022 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79080622 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78842295 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76647181 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76046896 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.74963246 |
| 105 | Mismatch repair_Homo sapiens_hsa03430 | 0.74279112 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74128757 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73978778 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73508599 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.72669786 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71567188 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71181333 |
| 112 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69717229 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69375724 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66303703 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65303056 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64579449 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64516577 |
| 118 | Renin secretion_Homo sapiens_hsa04924 | 0.63555661 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63337649 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63179900 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62774822 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.62405696 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60712628 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60515110 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59933478 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59510208 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59275205 |
| 128 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58704986 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.58475462 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57355755 |
| 131 | Legionellosis_Homo sapiens_hsa05134 | 0.56583960 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56204837 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55672502 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55046168 |
| 135 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53311803 |
| 136 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52825123 |
| 137 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52554353 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51222778 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51167418 |
| 140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51010797 |
| 141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50224972 |
| 142 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49277118 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47035528 |
| 144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44237331 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44228052 |
| 146 | Purine metabolism_Homo sapiens_hsa00230 | 0.44214242 |
| 147 | Homologous recombination_Homo sapiens_hsa03440 | 0.43790930 |
| 148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43389755 |
| 149 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42635147 |
| 150 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42372174 |
| 151 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41581776 |
| 152 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41519898 |
| 153 | Spliceosome_Homo sapiens_hsa03040 | 0.40822584 |
| 154 | Ribosome_Homo sapiens_hsa03010 | 0.40071761 |
| 155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39700433 |
| 156 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38903317 |
| 157 | Bile secretion_Homo sapiens_hsa04976 | 0.38278268 |
| 158 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37489086 |
| 159 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36249348 |
| 160 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35455478 |
| 161 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34969025 |
| 162 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34528261 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.33254074 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30254837 |
| 165 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28860252 |
| 166 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28592230 |
| 167 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26521509 |
| 168 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.24761214 |
| 169 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24270075 |

